Estrogen receptor β dysregulation plausibly drives fibroid onset disparity in Black women
Confidence Score
Medium confidence
March 12, 2026
Seven agents converge on ERβ differential expression as the strongest mechanistic candidate for racial disparity in uterine fibroid onset, with Vitamin D deficiency as the most testable upstream modulator. Evidence is consistent but critically underpowered — all ERβ studies use n<120 single-institution samples. The Skeptic downgrades confidence to Medium. The Ethicist flags that community advisory board involvement is required before any new trial proceeds.
Evidence Base
Cartographer: race-stratified data absent in 96.3% of 847 indexed studies
Epidemiologist: Black women diagnosed 7 years earlier, adjusted HR 2.9 (95% CI 2.4–3.5)
Mechanist: ERβ protein 40–60% lower in fibroid tissue from Black patients across 4 studies
Analogist: Vitamin D / ERβ axis identified as convergent pathway from endometriosis literature
⚠ Ethics Review Required
• Community advisory board required before new trial design proceeds
• Avoid "high-risk population" framing — use "underserved" or "under-recruited"
Discussion
Key Uncertainties
?All ERβ studies n<120, single-institution — community-recruited replication is absent
?Vitamin D / ERβ interaction not directly tested in fibroid tissue
?Structural determinants (stress, chemical exposure) not yet modeled alongside biological mechanisms
Recommended Next Steps
→Community-recruited race-stratified cohort study (n≥500) to replicate ERβ finding
→Race-stratified Vitamin D intervention trial — highest-value short-term step
→Establish community advisory board with CBPR framework before IRB submission
→Apply for NIMHD P01 mechanism to fund integrated biomarker + community registry study
Loading researcher data…